Financials Macro Group Pharmaceuticals (Macro Capital) S.A.E
Stocks
MCRO
EGS7D971C011
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.270 EGP | +3.25% |
|
+6.72% | +11.40% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Projected Income Statement: Macro Group Pharmaceuticals (Macro Capital) S.A.E
| Fiscal Period: December | 2021 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Net sales 1 | - | - | 1,190 | 1,552 | 1,946 |
| Change | - | - | - | 30.42% | 25.39% |
| EBITDA 1 | - | - | 271 | 381 | 504 |
| Change | - | - | - | 40.59% | 32.28% |
| EBIT 1 | - | - | 234 | 360 | 481 |
| Change | - | - | - | 53.85% | 33.61% |
| Interest Paid | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | - | 231 | 364 | 480 |
| Change | - | - | - | 57.58% | 31.87% |
| Net income 1 | 147.9 | 115.7 | 206 | 283 | 373 |
| Change | - | - | 78% | 37.38% | 31.8% |
| Announcement Date | 3/7/22 | 2/19/26 | - | - | - |
1EGP in Million
Estimates
Forecast Balance Sheet: Macro Group Pharmaceuticals (Macro Capital) S.A.E
| Fiscal Period: December | 2021 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | -79.7 | -110 | -268 |
| Change | - | - | - | -38.02% | -143.64% |
| Announcement Date | 3/7/22 | 2/19/26 | - | - | - |
1EGP in Million
Estimates
Cash Flow Forecast: Macro Group Pharmaceuticals (Macro Capital) S.A.E
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| CAPEX 1 | 71.4 | 31 | 29.2 |
| Change | - | -56.58% | -5.81% |
| Free Cash Flow (FCF) 1 | 47.1 | 179 | 346 |
| Change | - | 280.04% | 93.3% |
| Announcement Date | - | - | - |
1EGP in Million
Estimates
Forecast Financial Ratios: Macro Group Pharmaceuticals (Macro Capital) S.A.E
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | - | - | - | - | - | 22.77% | 24.55% | 25.9% |
| EBIT Margin (%) | - | - | - | - | - | 19.66% | 23.2% | 24.72% |
| EBT Margin (%) | - | - | - | - | - | 19.41% | 23.45% | 24.67% |
| Net margin (%) | - | - | - | - | - | 17.31% | 18.23% | 19.17% |
| FCF margin (%) | - | - | - | - | - | 3.96% | 11.53% | 17.78% |
| FCF / Net Income (%) | - | - | - | - | - | 22.86% | 63.25% | 92.76% |
Profitability | ||||||||
| ROA | - | - | - | - | - | 23.1% | 25% | 26.2% |
| ROE | - | - | - | - | - | 53.7% | 44.1% | 46.3% |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Debt / Free cash flow | - | - | - | - | - | - | - | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | - | - | - | - | - | 6% | 2% | 1.5% |
| CAPEX / EBITDA (%) | - | - | - | - | - | 26.35% | 8.14% | 5.79% |
| CAPEX / FCF (%) | - | - | - | - | - | 151.59% | 17.32% | 8.44% |
Items per share | ||||||||
| Cash flow per share 1 | - | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Dividend per Share 1 | - | - | - | - | - | 0.03 | 0.04 | 0.06 |
| Change | - | - | - | - | - | - | 33.33% | 50% |
| Book Value Per Share 1 | - | - | - | - | - | 0.17 | 0.22 | 0.27 |
| Change | - | - | - | - | - | - | 29.41% | 22.73% |
| EPS 1 | 0.26 | - | - | - | 0.2 | 0.06 | 0.09 | 0.11 |
| Change | - | - | - | - | - | -70% | 50% | 22.22% |
| Nbr of stocks (in thousands) | - | - | - | - | 570,206 | 570,206 | 570,206 | 570,206 |
| Announcement Date | 3/7/22 | - | - | - | 2/19/26 | - | - | - |
1EGP
Estimates
| 2026 * | 2027 * | |
|---|---|---|
| P/E | 21x | 14x |
| PBR | 7.41x | 5.73x |
| EV / Sales | 0.54x | 0.39x |
| Yield | 2.38% | 3.17% |
EPS & Dividend
Y-o-Y evolution of P/E
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.260EGP
Average target price
1.570EGP
Spread / Average Target
+24.60%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
- Financials Macro Group Pharmaceuticals (Macro Capital) S.A.E
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
